Enoch Muyanja
Enoch Muyanja
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
1,
Aloysius Ssemaganda
Aloysius Ssemaganda
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
1,
Pearline Ngauv
Pearline Ngauv
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
2,
Rafael Cubas
Rafael Cubas
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
2,
Helene Perrin
Helene Perrin
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
2,
Divya Srinivasan
Divya Srinivasan
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
2,
Glenda Canderan
Glenda Canderan
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
2,
Benton Lawson
Benton Lawson
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
3,
Jakub Kopycinski
Jakub Kopycinski
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
4,
Amanda S Graham
Amanda S Graham
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
5,
Dawne K Rowe
Dawne K Rowe
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
5,
Michaela J Smith
Michaela J Smith
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
5,
Denis Gaucher
Denis Gaucher
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
6,
Sharon Isern
Sharon Isern
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
5,
Scott Michael
Scott Michael
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
5,
Guido Silvestri
Guido Silvestri
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
3,
Thomas H Vanderford
Thomas H Vanderford
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
3,
Erika Castro
Erika Castro
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
7,
Giuseppe Pantaleo
Giuseppe Pantaleo
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
7,8,
Joel Singer
Joel Singer
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
9,
Jill Gillmour
Jill Gillmour
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
4,
Noah Kiwanuka
Noah Kiwanuka
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
1,10,
Annet Nanvubya
Annet Nanvubya
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
1,
Claudia Schmidt
Claudia Schmidt
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
11,
Josephine Birungi
Josephine Birungi
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
1,
Josephine Cox
Josephine Cox
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
4,
Elias K Haddad
Elias K Haddad
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
2,
Pontiano Kaleebu
Pontiano Kaleebu
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
1,12,
Patricia Fast
Patricia Fast
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
11,
Rafick-Pierre Sekaly
Rafick-Pierre Sekaly
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
2,
Lydie Trautmann
Lydie Trautmann
1Uganda Virus Research Institute–International AIDS
Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI),
Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint
Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine
Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human
Immunology Laboratory, Imperial College, London, United Kingdom. 5Department
of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA.
6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec,
Canada. 7Division of Immunology and Allergy, Lausanne University Hospital,
University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research
Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network,
Vancouver, British Columbia, Canada. 10Makerere University School of Public
Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York,
New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe,
Uganda.
2
